LONG FOCUS CAPITAL MANAGEMENT, LLC Adaptimmune Therapeutics plc Transaction History

LONG FOCUS CAPITAL MANAGEMENT, LLC portfolio value:

$5.14M
portfolio value

LONG FOCUS CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-36.76%
quarter

Adaptimmune Therapeutics plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +2.35% 109.99K shares -2.80M $1.08 4.78M
Q2 2022 share Increase +5.64% 250K shares -1.17M $1.7 4.67M
Q1 2022 share Increase +104.85% 2.26M shares 1.01M $2.06 4.42M
Q4 2021 share Increase 0.00% 2.16M shares 8.10M $3.87 2.16M